Denali Therapeutics Inc (DNLI)
16.15
+0.71
(+4.60%)
USD |
NASDAQ |
May 01, 16:00
16.15
0.00 (0.00%)
After-Hours: 18:10
Denali Therapeutics Market Cap: 2.302B for May 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 30, 2024 | 2.201B |
| April 29, 2024 | 2.224B |
| April 26, 2024 | 2.199B |
| April 25, 2024 | 2.132B |
| April 24, 2024 | 2.218B |
| April 23, 2024 | 2.296B |
| April 22, 2024 | 2.279B |
| April 19, 2024 | 2.281B |
| April 18, 2024 | 2.366B |
| April 17, 2024 | 2.398B |
| April 16, 2024 | 2.472B |
| April 15, 2024 | 2.543B |
| April 12, 2024 | 2.603B |
| April 11, 2024 | 2.732B |
| April 10, 2024 | 2.626B |
| April 09, 2024 | 2.771B |
| April 08, 2024 | 2.714B |
| April 05, 2024 | 2.764B |
| April 04, 2024 | 2.706B |
| April 03, 2024 | 2.760B |
| April 02, 2024 | 2.762B |
| April 01, 2024 | 2.930B |
| March 28, 2024 | 2.922B |
| March 27, 2024 | 2.958B |
| March 26, 2024 | 2.831B |
| Date | Value |
|---|---|
| March 25, 2024 | 2.830B |
| March 22, 2024 | 2.794B |
| March 21, 2024 | 2.991B |
| March 20, 2024 | 3.032B |
| March 19, 2024 | 2.925B |
| March 18, 2024 | 2.861B |
| March 15, 2024 | 2.867B |
| March 14, 2024 | 2.812B |
| March 13, 2024 | 2.976B |
| March 12, 2024 | 2.958B |
| March 11, 2024 | 3.089B |
| March 08, 2024 | 2.981B |
| March 07, 2024 | 2.924B |
| March 06, 2024 | 2.922B |
| March 05, 2024 | 2.912B |
| March 04, 2024 | 2.942B |
| March 01, 2024 | 2.971B |
| February 29, 2024 | 2.817B |
| February 28, 2024 | 2.812B |
| February 27, 2024 | 3.249B |
| February 26, 2024 | 2.350B |
| February 23, 2024 | 2.356B |
| February 22, 2024 | 2.342B |
| February 21, 2024 | 2.300B |
| February 20, 2024 | 2.302B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.382B
Minimum
Oct 18 2019
11.22B
Maximum
Dec 22 2020
4.035B
Average
3.554B
Median
Market Cap Benchmarks
| Halozyme Therapeutics Inc | 4.982B |
| AIM ImmunoTech Inc | 19.46M |
| Perspective Therapeutics Inc | 1.007B |
| Protalix BioTherapeutics Inc | 88.39M |
| Armata Pharmaceuticals Inc | 86.75M |
Market Cap Related Metrics
| PS Ratio | 6.555 |
| Price to Book Value | 2.233 |
| Price | 16.15 |
| Earnings Yield | -6.69% |